“B5H7, a Morpholine Derivative of 23-Hydroxybetulinic Acid, Reverses Doxorubicin Resistance in HepG2 ADM”. Journal of Cancer Research Updates, vol. 3, no. 1, Jan. 2014, pp.  59-66, https://doi.org/10.6000/1929-2279.2014.03.01.6.